Edition:
United Kingdom

Manas Mishra

Joining a choir may help elders enjoy life

06 Dec 2018

(Reuters Health) - - Singing in a community choir may provide some psychological benefit to seniors, a small study suggests.

Astellas Pharma gets U.S. nod for blood cancer treatment

28 Nov 2018

The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.

UPDATE 2-Astellas Pharma gets U.S. nod for blood cancer treatment

28 Nov 2018

Nov 28 The U.S. Food and Drug Administration on Wednesday approved a blood cancer treatment from Japan's Astellas Pharma Inc, making it the first targeted therapy to treat patients with a certain mutation.

Health stocks up on U.S. vote; insurers hit records

07 Nov 2018

Shares in drugmakers and U.S. health insurers rallied on Wednesday, after election results delivered a split Congress that is unlikely to significantly cut government healthcare programs or reduce drug prices in the world's biggest and most profitable market.

CVS quarterly profit beats; expects to close Aetna deal this month

06 Nov 2018

CVS Health Corp , which expects to close its $69 billion purchase of Aetna Inc this month, reported third-quarter profit that beat analysts' estimates on higher sales of prescription drugs.

UPDATE 2-U.S. FDA approves AcelRx Pharma's opioid pain drug

02 Nov 2018

Nov 2 The U.S. Food and Drug Administration on Friday approved AcelRx Pharmaceuticals Inc's opioid-based treatment for pain to be used under strict medical supervision, with the agency's chief highlighting reasons for the approval in a rare move.

Cigna boosts 2018 forecast after third quarter earnings beat

01 Nov 2018

U.S. health insurer Cigna Corp , which is in the process of acquiring Express Scripts Holding Co , significantly bumped up its 2018 adjusted profit forecast, and its shares rose more than 3 percent on Thursday.

Allergan says offers undervalue business units for sale, shares fall

30 Oct 2018

Allergan Plc on Tuesday expressed disappointment in early offers from potential buyers for business units it has been trying to sell, and its shares fell more than 6 percent.

Merck, Bristol-Myers profits rise on cancer drug sales

25 Oct 2018

Merck & Co Inc and Bristol-Myers Squibb Co posted better-than-expected third quarter profit and raised their 2018 earnings forecasts on Thursday due to strong demand for their rival cancer immuno-oncology treatments.

Cancer drug Keytruda powers Merck's profit beat, forecast raise

25 Oct 2018

Merck & Co Inc said on Thursday sales of its blockbuster cancer immunotherapy Keytruda nearly doubled in the third quarter, helping the drugmaker beat profit estimates and lift its adjusted earnings forecast for the year.

World News